Downregulation of Scar Fibroblasts by Antineoplastic Drugs: A Potential Treatment for Fibroproliferative Disorders

Journals Menu

Follow SCIRP

ISSN Print: 2157-9407
ISSN Online: 2157-9415
www.scirp.org/journal/ss
E-mail: ss@scirp.org

Citations h5-index & Ranking

"Downregulation of Scar Fibroblasts by Antineoplastic Drugs: A Potential Treatment for Fibroproliferative Disorders"
written by M. Georgina Uberti, Yvonne N. Pierpont, Rajat Bhalla, Karan Desai, Martin C. Robson, Wyatt G. Payne,
published by Surgical Science, Vol.7 No.6, 2016

has been cited by the following article(s):

[1]	Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease
	2020

[2]	Investigating the effect of phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in models of Peyronie's disease
	2019

Follow SCIRP